(HLNE) Hamilton Lane - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4074971064
HLNE: Private Equity, Venture Capital, Alternative Investments, Funds
Hamilton Lane Incorporated (NASDAQ:HLNE) is a leading global alternative investment manager with a strong focus on private equity, venture capital, and alternative investment strategies. Founded in 1991 and headquartered in Conshohocken, Pennsylvania, the firm has established itself as a trusted partner for institutional investors, family offices, and high-net-worth individuals seeking access to the private markets.
HLNE specializes in a wide range of investment strategies, including direct credit, direct equity, fund of funds, evergreen funds, and real assets. The firm’s expertise spans multiple geographies, with a presence in key markets across North America, Europe, Asia Pacific, and the Middle East. This global reach allows Hamilton Lane to identify and capitalize on emerging opportunities while managing risk effectively.
The firm’s investment approach is highly diversified, both in terms of sectors and geographies. It targets sectors such as energy, industrials, healthcare, technology, consumer discretionary, and financials, among others. Geographically, HLNE invests across Africa/Middle East, Asia/Pacific, Europe, Latin America, the United States, and Canada, demonstrating a broad and balanced approach to portfolio construction.
Hamilton Lane is known for its ability to invest across the entire private market spectrum, from early-stage venture capital to mature buyouts. The firm’s typical investment size ranges from $1 million to $100 million, with a preference for small- to mid-sized enterprises. It often seeks majority stakes, reflecting its confidence in its due diligence and strategic alignment with portfolio companies.
As a publicly traded company, HLNE offers investors a unique opportunity to gain exposure to the private markets through its stock. With a market capitalization of approximately $8.65 billion and a price-to-earnings ratio of 28.06, the firm is valued for its consistent performance and strong track record. Its price-to-book ratio of 10.13 reflects the market’s confidence in its ability to generate returns and manage alternative assets effectively.
Hamilton Lane’s reputation as a leader in alternative investments is built on its long-term performance, rigorous research, and collaborative approach with its clients. For investors and fund managers, HLNE represents a compelling option for diversifying portfolios and accessing the private markets through a proven and experienced platform.
Additional Sources for HLNE Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HLNE Stock Overview
Market Cap in USD | 8,655m |
Sector | Financial Services |
Industry | Asset Management |
GiC Sub-Industry | Asset Management & Custody Banks |
IPO / Inception | 2017-03-01 |
HLNE Stock Ratings
Growth 5y | 75.2% |
Fundamental | 44.0% |
Dividend | 65.1% |
Rel. Strength Industry | 1.07 |
Analysts | 2.86/5 |
Fair Price Momentum | 136.87 USD |
Fair Price DCF | 40.82 USD |
HLNE Dividends
Dividend Yield 12m | 1.30% |
Yield on Cost 5y | 3.06% |
Annual Growth 5y | 9.54% |
Payout Consistency | 100.0% |
HLNE Growth Ratios
Growth Correlation 3m | -48% |
Growth Correlation 12m | 84.9% |
Growth Correlation 5y | 70.9% |
CAGR 5y | 19.32% |
CAGR/Max DD 5y | 0.40 |
Sharpe Ratio 12m | 0.83 |
Alpha | 4.45 |
Beta | 1.29 |
Volatility | 36.85% |
Current Volume | 641.6k |
Average Volume 20d | 571.8k |
As of February 22, 2025, the stock is trading at USD 151.46 with a total of 641,616 shares traded.
Over the past week, the price has changed by -3.03%, over one month by -3.61%, over three months by -23.35% and over the past year by +31.43%.
Partly, yes. Based on ValueRay Fundamental Analyses, Hamilton Lane (NASDAQ:HLNE) is currently (February 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 43.95 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HLNE as of February 2025 is 136.87. This means that HLNE is currently overvalued and has a potential downside of -9.63%.
Hamilton Lane has received a consensus analysts rating of 2.86. Therefor, it is recommend to hold HLNE.
- Strong Buy: 0
- Buy: 0
- Hold: 6
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, HLNE Hamilton Lane will be worth about 164.3 in February 2026. The stock is currently trading at 151.46. This means that the stock has a potential upside of +8.44%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 172.7 | 14% |
Analysts Target Price | 177.2 | 17% |
ValueRay Target Price | 164.3 | 8.4% |